Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Cancer Sci. 2022 Mar;113(3):926-939. doi: 10.1111/cas.15265. Epub 2022 Jan 17.
C-X-C motif chemokine receptor 4 (CXCR4) belongs to the CXC chemokine receptor family, which mediates the metastasis of tumor cells and promotes the malignant development of cancers. However, its biological role and regulatory mechanism in esophageal squamous cell carcinoma (ESCC) remain unclear. Here, we found that CXCR4 expression was associated with lymph node metastasis and a poor prognosis. In vitro and in vivo studies demonstrated that CXCR4 overexpression promoted ESCC cell proliferation, migration, invasion, and survival, whereas silencing CXCR4 induced the opposite effects. Mechanically, HIF-1α transcriptionally regulates CXCR4 expression by binding to a hypoxia response element in its promoter. HIF-1α-induced ESCC cell migration and invasion were reversed by CXCR4 knockdown or treatment with MSX-122, a CXCR4 antagonist. Collectively, these data revealed that the HIF-1α/CXCR4 axis plays key roles in ESCC growth and metastasis and indicated CXCR4 as a potential target for ESCC treatment.
C-X-C 基序趋化因子受体 4(CXCR4)属于 CXC 趋化因子受体家族,介导肿瘤细胞的转移,并促进癌症的恶性发展。然而,其在食管鳞状细胞癌(ESCC)中的生物学作用和调节机制尚不清楚。在这里,我们发现 CXCR4 的表达与淋巴结转移和预后不良有关。体外和体内研究表明,CXCR4 过表达促进 ESCC 细胞增殖、迁移、侵袭和存活,而沉默 CXCR4 则诱导相反的效果。机制上,HIF-1α 通过结合其启动子中的缺氧反应元件来转录调节 CXCR4 的表达。CXCR4 敲低或 CXCR4 拮抗剂 MSX-122 处理可逆转 HIF-1α 诱导的 ESCC 细胞迁移和侵袭。总之,这些数据表明 HIF-1α/CXCR4 轴在 ESCC 的生长和转移中起关键作用,并表明 CXCR4 是 ESCC 治疗的潜在靶点。